$466 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 64 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
U | Exit | UNITY SOFTWARE INC | $0 | – | -11,500 | -100.0% | -0.05% | – |
Exit | WIX COM LTDnote 8/1 | $0 | – | -700,000 | -100.0% | -0.08% | – | |
EWTX | Exit | EDGEWISE THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.08% | – |
NICE | Exit | NICE LTDsponsored adr | $0 | – | -3,145 | -100.0% | -0.08% | – |
ICL | Exit | ICL GROUP LTD | $0 | – | -111,482 | -100.0% | -0.13% | – |
MDWD | Exit | MEDIWOUND LTD | $0 | – | -688,716 | -100.0% | -0.13% | – |
PSTX | Exit | POSEIDA THERAPEUTICS INC | $0 | – | -300,000 | -100.0% | -0.15% | – |
VRNA | Exit | VERONA PHARMA PLCsponsored ads | $0 | – | -120,000 | -100.0% | -0.17% | – |
Exit | ALTIMMUNE INCput | $0 | – | -100,000 | -100.0% | -0.18% | – | |
RUN | Exit | SUNRUN INC | $0 | – | -65,000 | -100.0% | -0.25% | – |
Exit | DICE THERAPEUTICS INCput | $0 | – | -150,000 | -100.0% | -0.42% | – | |
Exit | DICE THERAPEUTICS INC | $0 | – | -152,913 | -100.0% | -0.43% | – | |
Exit | RELMADA THERAPEUTICS INCput | $0 | – | -93,000 | -100.0% | -0.48% | – | |
Exit | SENTINELONE INCcall | $0 | – | -164,800 | -100.0% | -0.58% | – | |
NVDA | Exit | NVIDIA CORPORATION | $0 | – | -40,000 | -100.0% | -0.67% | – |
TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $0 | – | -776,346 | -100.0% | -0.87% | – |
Exit | GENERAC HLDGS INCcall | $0 | – | -35,600 | -100.0% | -0.88% | – | |
GILD | Exit | GILEAD SCIENCES INC | $0 | – | -105,090 | -100.0% | -0.90% | – |
SEDG | Exit | SOLAREDGE TECHNOLOGIES INC | $0 | – | -29,426 | -100.0% | -0.94% | – |
RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -193,230 | -100.0% | -0.99% | – |
S | Exit | SENTINELONE INCcl a | $0 | – | -280,000 | -100.0% | -0.99% | – |
Exit | PERION NETWORK LTD | $0 | – | -405,184 | -100.0% | -1.08% | – | |
ADBE | Exit | ADOBE SYSTEMS INCORPORATED | $0 | – | -29,150 | -100.0% | -1.11% | – |
GLBE | Exit | GLOBAL E ONLINE LTD | $0 | – | -311,460 | -100.0% | -1.16% | – |
KRNT | Exit | KORNIT DIGITAL LTD | $0 | – | -322,926 | -100.0% | -1.19% | – |
WIX | Exit | WIX COM LTD | $0 | – | -129,000 | -100.0% | -1.40% | – |
PANW | Exit | PALO ALTO NETWORKS INC | $0 | – | -63,000 | -100.0% | -1.43% | – |
Exit | UNITY SOFTWARE INCcall | $0 | – | -367,500 | -100.0% | -1.62% | – | |
Exit | NVIDIA CORPORATIONcall | $0 | – | -172,600 | -100.0% | -2.91% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
BIOGEN INC | 26 | Q3 2023 | 6.7% |
AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
PFIZER INC | 25 | Q3 2023 | 9.2% |
SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
UNIQURE NV | 23 | Q3 2023 | 1.2% |
SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-02-15 |
13F-HR | 2024-02-14 |
SC 13G | 2024-02-08 |
SC 13G/A | 2024-02-05 |
SC 13G/A | 2024-02-05 |
SC 13G/A | 2024-02-05 |
SC 13G/A | 2024-02-05 |
13F-HR | 2023-11-14 |
SC 13G | 2023-10-10 |
SC 13G | 2023-08-30 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.